Antihistamine for Prevention of HTR After Blood Primed CPB — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Antihistamine for Prevention of HTR After Blood Primed CPB — Stella

Recruiting

Back to Blood Transfusion Associated Adverse Reactions trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Egypt

Misr Universty for Scince and Technology, Giza, October

Key details

Phase

Post-approval study

Sponsor

Kasr El Aini Hospital

Collaborators

Misr University for Science and Technology

Enrollment target

~40 participants

Started

March 2026

Primary completion

November 2026

Age range

1 Year – 7 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov